000 | 01511 a2200421 4500 | ||
---|---|---|---|
005 | 20250518001331.0 | ||
264 | 0 | _c20200921 | |
008 | 202009s 0 0 eng d | ||
022 | _a1365-2133 | ||
024 | 7 |
_a10.1111/bjd.17253 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeon, J L | |
245 | 0 | 0 |
_aNovel therapeutic approaches to xeroderma pigmentosum. _h[electronic resource] |
260 |
_bThe British journal of dermatology _c08 2019 |
||
300 |
_a249-255 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAcetohexamide _xpharmacology |
650 | 0 | 4 | _aAdministration, Cutaneous |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCaloric Restriction |
650 | 0 | 4 |
_aDNA Damage _xdrug effects |
650 | 0 | 4 |
_aDNA Repair _xdrug effects |
650 | 0 | 4 |
_aDermatology _xmethods |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNiacinamide _xpharmacology |
650 | 0 | 4 | _aProtective Clothing |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aSulfonylurea Compounds _xpharmacology |
650 | 0 | 4 |
_aSunlight _xadverse effects |
650 | 0 | 4 |
_aSunscreening Agents _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUltraviolet Rays _xadverse effects |
650 | 0 | 4 |
_aXeroderma Pigmentosum _xgenetics |
700 | 1 | _aGlass, D A | |
773 | 0 |
_tThe British journal of dermatology _gvol. 181 _gno. 2 _gp. 249-255 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.17253 _zAvailable from publisher's website |
999 |
_c28884736 _d28884736 |